M Yakushiji

2.1k total citations
161 papers, 1.7k citations indexed

About

M Yakushiji is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, M Yakushiji has authored 161 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Reproductive Medicine, 36 papers in Oncology and 31 papers in Obstetrics and Gynecology. Recurrent topics in M Yakushiji's work include Ovarian cancer diagnosis and treatment (77 papers), Endometrial and Cervical Cancer Treatments (21 papers) and Testicular diseases and treatments (12 papers). M Yakushiji is often cited by papers focused on Ovarian cancer diagnosis and treatment (77 papers), Endometrial and Cervical Cancer Treatments (21 papers) and Testicular diseases and treatments (12 papers). M Yakushiji collaborates with scholars based in Japan, United States and Sweden. M Yakushiji's co-authors include Takashi Nishida, Toru Sugiyama, Akio Kataoka, Gonosuke Sonoda, Stanislas du Manoir, Joseph R. Testa, Andrew K. Godwin, Takashi Nishida, Kimio Ushijima and Juan Palazzo and has published in prestigious journals such as Cancer, British Journal of Cancer and Annals of Oncology.

In The Last Decade

M Yakushiji

150 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Yakushiji Japan 23 772 470 465 424 417 161 1.7k
Toshio Hirakawa Japan 25 893 1.2× 573 1.2× 524 1.1× 288 0.7× 339 0.8× 55 1.8k
A.G.J. van der Zee Netherlands 24 434 0.6× 593 1.3× 318 0.7× 301 0.7× 528 1.3× 53 1.6k
Vicki V. Baker United States 22 299 0.4× 498 1.1× 418 0.9× 353 0.8× 442 1.1× 62 1.6k
M. Baekelandt Norway 24 664 0.9× 437 0.9× 426 0.9× 308 0.7× 525 1.3× 55 1.4k
C. Mangioni Italy 19 901 1.2× 209 0.4× 584 1.3× 516 1.2× 409 1.0× 52 1.6k
J. J. Kavanagh United States 17 545 0.7× 308 0.7× 232 0.5× 303 0.7× 396 0.9× 50 1.2k
Gustavo C. Rodriguez United States 29 1.2k 1.5× 781 1.7× 607 1.3× 340 0.8× 733 1.8× 78 2.7k
Vanda Salutari Italy 23 722 0.9× 333 0.7× 412 0.9× 291 0.7× 555 1.3× 110 1.5k
Masato Nishida Japan 24 968 1.3× 405 0.9× 888 1.9× 492 1.2× 276 0.7× 96 2.1k
Marta A. Crispens United States 25 723 0.9× 568 1.2× 447 1.0× 177 0.4× 498 1.2× 62 1.8k

Countries citing papers authored by M Yakushiji

Since Specialization
Citations

This map shows the geographic impact of M Yakushiji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Yakushiji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Yakushiji more than expected).

Fields of papers citing papers by M Yakushiji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Yakushiji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Yakushiji. The network helps show where M Yakushiji may publish in the future.

Co-authorship network of co-authors of M Yakushiji

This figure shows the co-authorship network connecting the top 25 collaborators of M Yakushiji. A scholar is included among the top collaborators of M Yakushiji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Yakushiji. M Yakushiji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sekiguchi, Hiroshi, et al.. (2005). A point mutation of the ED1 gene in a Japanese family with X‐linked hypohidrotic ectodermal dysplasia. International Journal of Paediatric Dentistry. 15(1). 73–77. 7 indexed citations
2.
Sugiyama, Toru, M Yakushiji, Kazunori Ochiai, & Kiichiro Noda. (2003). Japanese ovarian trials: focus on irinotecan.. PubMed. 17(5 Suppl 5). 29–33. 3 indexed citations
3.
Sugiyama, Toru, M Yakushiji, Toshiharu Kamura, et al.. (2002). Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer. Oncology. 63(1). 16–22. 25 indexed citations
4.
Fujiwara, Keiichi, Ichiro Kohno, Katsuaki Tanaka, et al.. (1999). Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.. PubMed. 19(1B). 639–44. 7 indexed citations
5.
Nishida, Takashi, et al.. (1999). Serous Adenocarcinofibroma of the Ovary. Report of Two Cases and Review of the Literature.. The Kurume Medical Journal. 46(2). 133–136. 1 indexed citations
6.
Ushijima, Kimio, Takashi Nishida, & M Yakushiji. (1998). Assessment of second‐look operations in malignant ovarian germ cell tumors. International Journal of Gynecology & Obstetrics. 60(3). 291–292. 1 indexed citations
7.
Mori, Mitsuru, Takashi Nishida, Toru Sugiyama, et al.. (1998). Anthropometric and Other Risk Factors for Ovarian Cancer in a Case‐Control Study. Japanese Journal of Cancer Research. 89(3). 246–253. 39 indexed citations
8.
Takano, Masashi, Hiroshi Aida, Ikunosuke Tsuneki, et al.. (1997). Mutational Analysis of BRCA1 Gene in Ovarian and Breast‐ovarian Cancer Families in Japan. Japanese Journal of Cancer Research. 88(4). 407–413. 19 indexed citations
9.
Yakushiji, M, et al.. (1997). Combination of CPT-11 with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer. Oncology Reports. 4(2). 345–8. 1 indexed citations
10.
Tetsuo, M., et al.. (1995). Evaluation of hemodynamic changes and intrauterine conversion of fetal supraventricular tachycardia. Acta Obstetricia Et Gynecologica Scandinavica. 74(8). 647–649. 2 indexed citations
11.
Yakushiji, M, et al.. (1994). Polyhydramnios: Ultrasonic Detection of Fetal and Maternal Conditions.. The Kurume Medical Journal. 41(1). 31–36. 7 indexed citations
12.
Kiyozuka, Yasuhiko, et al.. (1994). Ovarian neuroblastoma due to malignant transformation of mature cystic teratoma: A clinicopathologic and immunohistologic analysis.. The Journal of the Japanese Society of Clinical Cytology. 33(4). 620–627. 1 indexed citations
13.
Yakushiji, M, et al.. (1993). Color and Pulsed Doppler Ultrasonography of Reversed Umbilical Blood Flow in an Acardiac Twin. Asia-Oceania Journal of Obstetrics and Gynaecology. 19(3). 271–275. 11 indexed citations
14.
Nishimura, Hideki, et al.. (1993). [Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro].. PubMed. 45(2). 125–32.
15.
Fujii, Junichi, Haruyuki Tatsumi, Toru Sugiyama, et al.. (1992). High expression of manganese superoxide dismutase in 7,12-dimethylbenz[a]anthracene-induced ovarian cancer and increased serum levels in the tumor-bearing rats. Carcinogenesis. 13(10). 1941–1943. 11 indexed citations
16.
17.
Nishimura, Haruo, et al.. (1992). Significance of the Serum CA125 Level in Recurrent Ovarian Cancer. Asia-Oceania Journal of Obstetrics and Gynaecology. 18(1). 37–43. 4 indexed citations
18.
Shirai, Masato, Yuji Sugawara, M Yakushiji, et al.. (1984). [Study of multiple gastric cancer].. PubMed. 29(7). 761–6. 2 indexed citations
19.
Yakushiji, M, et al.. (1974). EXPERIMENTAL STUDIES ON THE MORPHOLOGIC CHANGES OF THE ENDOMETRIUM FOLLOWING ESTROGEN AND PROGESTERONE ADMINISTRATION. The Kurume Medical Journal. 21(1). 23–33. 1 indexed citations
20.
Ashida, Shingo, et al.. (1962). [2 cases of gastric leiomyoma, with special reference to the roentgenogram].. PubMed. 7. 601–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshio Hirakawa Breakdown of academic impact, for papers by A.G.J. van der Zee Breakdown of academic impact, for papers by Vicki V. Baker Breakdown of academic impact, for papers by M. Baekelandt Breakdown of academic impact, for papers by C. Mangioni Breakdown of academic impact, for papers by J. J. Kavanagh Breakdown of academic impact, for papers by Gustavo C. Rodriguez Breakdown of academic impact, for papers by Vanda Salutari Breakdown of academic impact, for papers by Masato Nishida Breakdown of academic impact, for papers by Marta A. Crispens
Rankless by CCL
2026